Volume 8, Issue 12 pp. 1420-1430
Full Access

Differential Effect of β-Adrenergic Stimulation on the Frequency-Dependent Electrophysiologic Actions of the New Class III Antiarrhythmics Dofetilide, Ambasilide, and Chromanol 293.

JÜRGEN SCHREIECK M.D.

Corresponding Author

JÜRGEN SCHREIECK M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Jürgen Schreieck, M.D., I. Medizinische Klinik, Technische Universität München, Klinikum rechts der Isar, Ismaninger Str. 22, 81675 München, Germany, Fax: 49-89-1218-4593.Search for more papers by this author
YANGGAN WANG M.D.

YANGGAN WANG M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Search for more papers by this author
VIKTOR GJINI M.D.

VIKTOR GJINI M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Search for more papers by this author
MICHAEL KORTH M.D.

MICHAEL KORTH M.D.

Institut für Pharmakologie, Universität Hamburg, Hamburg, Germany

Search for more papers by this author
BERNHARD ZRENNER M.D.

BERNHARD ZRENNER M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Search for more papers by this author
ALBERT SCHÖMIG M.D.

ALBERT SCHÖMIG M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Search for more papers by this author
CLAUS SCHMITT M.D.

CLAUS SCHMITT M.D.

I. Medizinische Klinik, Klinikum rechts der Isar and Klinik für Herzkreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

Search for more papers by this author
First published: 20 April 2007
Citations: 48

This work was supported by a grant from the Lilly Foundation.

Presented in part at the 45th Annual Scientific Session of the American College of Cardiology. Orlando, Florida. March 27, 1996.

Abstract

Class III Antiarrhythmics and β-Adrenergic Stimulation. Introduction: Blockade of the rapid delayed rectifier potassium current (IKr) as an important mechanism for current Class III antiarrhythmics is less effective in action potential prolongation during β-adrenergic activation. We hypothesized that blockade of the increased slow IK (IKs) current during β-adrenergic stimulation could improve action potential prolongation and tested this hypothesis by comparison of three different IK blockers: dofetilide, a selective blocker of IKr; ambasilide, a nonselective blocker of IK; and chromanol 293B, a selective blocker of IKs.

Methods and Results: Transmembrane action potential duration was determined in guinea pig papillary muscles. After equilibration with the potassium channel blockers (dofetilide 10 nM, amhasilide 10 μM, chromanol 293B 10 μM), isoproterenol (10 and 100 nM) was added. The action potential prolonging effect of dofetilide was reduced in the presence of increasing concentrations of isoproterenol whereas the effect of ambasilide was much less reduced. In contrast, the effect of chromanol 293B clearly was increased in the presence of both concentrations of isoproterenol. No afterdepolarizations were observed after application of isoproterenol in control. Following isoproterenol, but not before, dofetilide and chromanol 293B induced early afterdepolarizations in 20% and 17% of the papillary muscles, whereas ambasilide and chromanol 293B induced delayed afterdepolarizations in 27% and 17%, respectively.

Conclusion: In contrast to dofetilide, the Class III effect of ambasilide is less reduced and the effect of chromanol 293B is enhanced during β-adrenergic stimulation. Our data support the hypothesis that IKs blockade improves the efficacy of antiarrhythmics in action potential prolongation during β-adrenergic activation; however, this effect may increase the risk of afterdepolarizations.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.